In response to Tumph with a Humanitarian aspect, India on tuesday announced a news. India has rescinded its earlier ban on the export of malaria drug hydroxychloroquine that is HCQ. This drug will be used for possible line of treatment for COVID19 in countries such as US.
In view of the humanitarian aspects of the pandemic, it has been decided that India would licence paracetamol and HCQ in appropriate quantities to all our neighbouring countries who are dependent on our capabilities. We will also be supplying these essential drugs to some nations that have been particularly badly affected by the pandemic,” Ministry of External Affairs spokesperson Anurag Srivastava said.
In a notification on March 25, the government placed HCQ on a restricted items list, and then put a blanket ban on any export of the drug on April 4. The latest decision, which was taken at a high-level meeting on April 6, effectively overturns the previous notification.
The MEA announcement came hours after U.S. President Donald Trump said that India could invite “retaliation” if it with held supplies of HCQ for which the U.S., Brazil and other countries have already placed advance orders.